Author

Norman Michael Drzeniek

Observed names: Drzeniek, Norman, Drzeniek, Norman M., N. Drzeniek, N.M. Drzeniek, Norman Drzeniek, Norman M Drzeniek, Norman M. Drzeniek

Institutions: Humboldt-Universität zu Berlin, University of Oxford, Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Kennedy Institute of Rheumatology, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, University of Pennsylvania

Observed institutions: Humboldt-Universität zu Berlin, University of Oxford, German Rheumatism Research Centre, Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Stiftung Charité, Kennedy Institute of Rheumatology, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, University of Pennsylvania

ORCID: 0000-0001-6562-2351

Observed ORCID: 0000-0001-6562-2351

OpenAlex ID: A5091805652

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

2020 · Guido Moll, Norman Drzeniek, et al. · Frontiers in Immunology · 176

Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells

2021 · Norman M Drzeniek, Andrea Mazzocchi, et al. · Biofabrication · 48

PDF

Implantable Biomaterials for Peripheral Nerve Regeneration–Technology Trends and Translational Tribulations

2022 · Angela Sanchez Rezza, Yalcin Kulahci, et al. · Frontiers in Bioengineering and Biotechnology · 43

PDF

Practical Applications of Large Language Models for Health Care Professionals and Scientists

2024 · Florian Reis, Christian Lenz, et al. · JMIR Medical Informatics · 20

PDF

In Vitro Transcribed mRNA Immunogenicity Induces Chemokine‐Mediated Lymphocyte Recruitment and Can Be Gradually Tailored by Uridine Modification

2024 · Norman M. Drzeniek, Nourhan Kahwaji, et al. · Advanced Science · 20

PDF

Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome

2022 · Norman Michael Drzeniek, Nourhan Kahwaji, et al. · Biomaterials · 16

Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease

2025 · Thorben Witte, Ioanna Minopoulou, et al. · Autoimmunity Reviews · 8

Long-term in vitro maintenance of plasma cells in a hydrogel-enclosed human bone marrow microphysiological 3D model system

2024 · Stefania Martini, Norman Michael Drzeniek, et al. · Biofabrication · 7

Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product

2020 · Guido Moll, Norman Drzeniek, et al. · British Journal of Haematology · 6

PDF

mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells

2026 · Nourhan Kahwaji, Niklas Kotzian, et al. · Molecular Therapy — Nucleic Acids · 5

PDF

Lipid nanoparticle mRNA delivery preserves CAR T cell cytotoxicity and limits exhaustion compared to electroporation

2026 · Samira Picht, Martí Farrera-Sal, et al. · Molecular Therapy — Nucleic Acids · 4

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series

2026 · Elise Siegert, Elpida Phithak, et al. · Annals of the Rheumatic Diseases · 3

PDF

BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease

2026 · Elpida Phithak, Fredrik Albach, et al. · Lara D. Veeken · 1

Tofacitinib‐Induced Weight Gain in Context: comment on the article by Wollenhaupt et al.

2026 · Andriko Palmowski, Frank Buttgereit, et al. · ACR Open Rheumatology · 1

PDF

Trust is all you Need: Reinforcing the Patient-physician Bond in Times of AI

2025 · Florian Reis, Moritz Reis, et al. · Journal of Medical Systems · 1

Pos0876 Effect of Anti-cd19 Car T Cell Therapy in the Bone Marrow of Patients With Systemic Autoimmune Diseases

2025 · I. Minopoulou, A. Wilhelm, et al. · Annals of the Rheumatic Diseases · 1

Revisiting the Need for mRNA Nucleoside Modification in CAR T Cell Engineering

2025 · Nourhan Kahwaji, Niklas Kotzian, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Comment on: Glucocorticoid discontinuation in systemic lupus erythematosus: a single-centre study

2025 · Andriko Palmowski, Anne E Beenken, et al. · Rheumatology Advances in Practice · 1

PDF

CARtalysts of Change

2026 · Norman Michael Drzeniek · CRC Press eBooks

A Non-Viral CRISPR/Cas9 HDR Platform for Stable Engineering of Solid Tumor Models

2026 · Shoaib Afzal, Maximilian Pilgram, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

POS0722 CHEMOKINE-ENGINEERED CAR-T CELLS FOR AUTOIMMUNITY: MULTIPLEXED mRNA TECHNOLOGY FOR IMPROVED MODE-OF-ACTION AND SAFETY

2025 · S. Picht, L. Hemmerling, et al. · Annals of the Rheumatic Diseases

Mesenchymal Stem/Stromal Cells: NEXT-GENERATION MESENCHYMAL STROMAL/STEM CELL THERAPEUTICS: HIGH-END PHENOTYPIC, AND FUNCTIONAL PROFILING OF THERAPEUTIC PLACENTA-DERIVED PLX-PAD CELL PRODUCTS FOR TREATMENT OF MULTIPLE CLINICAL INDICATIONS

2023 · G. Moll, S. Schlickeiser, et al. · Cytotherapy

Works count: 26

Citation count: 366

H-index: 7

I10-index: 6